PrEP: Preventative HIV drug highly effective, study says

PrEP: Preventative HIV drug highly effective, study says

Dr John Saunders, a consultant in sexual health and HIV who worked on the study, said: “This trial has further demonstrated the effectiveness of PrEP in preventing HIV transmission and has, for the first time, shown the protective effect reported by earlier trials, but at scale, and delivered through routine sexual health services in England.” … Read more

HIV Prevention Has An Equity Problem. Here’s What Needs to Change

Michael Chancley, communications director, PrEP4All, and PrEP user. AIDSVu.org: “Local Data: Louisiana.” CDC.gov: “HIV and Women: HIV Diagnoses,” “HIV Surveillance Data Tables. Table 3a,” “PrEP Effectiveness,” FDA.gov: “FDA Approves First Injectable Treatment for HIV Pre-Exposure Prophylaxis,” Dec. 20, 2021, “FDA approves second drug to prevention HIV infection as part of ongoing efforts to end the … Read more

FDA Approves First Injection Regimen for HIV Prevention

By Robert Preidt and Robin Foster HealthDay Reporters TUESDAY, Dec. 21, 2021 (HealthDay News) — The first injection drug to prevent HIV infection was approved by the U.S. Food and Drug Administration on Monday. “Today’s approval adds an important tool in the effort to end the HIV epidemic by providing the first option to prevent … Read more

Re-Aligned U.S. HIV Panel Works to Rebuild Community Bridges

In August, when Assistant Secretary for Health Rachel Levine swore in eight new members to the President’s Advisory Council on HIV/AIDS (PACHA), the U.S.’s most influential policy sounding board of people living with HIV, their clinicians, drug makers, and public health leaders, she was presiding over the largest group of HIV advisers since former President … Read more

Why the CDC Doesn’t Recommend Screening Straight Men for STDs

While screening younger women and men who have sex with men for STIs could help prevent more serious health problems down the line, the potential health benefits for heterosexual men are not as clear. “Data are insufficient to draw definitive conclusions about the effectiveness of screening heterosexual men at low risk for gonorrhea and … Read more

PrEP HIV Prevention Pills to Be Free for Insured Americans

By Robert Preidt and Robin FosterHealthDay Reporter WEDNESDAY, July 21, 2021 (HealthDay News) — Nearly all health insurers must cover the entire cost of HIV prevention treatments, the U.S. government says. That includes the two approved pre-exposure prophylaxis (PrEP) drugs Truvada and Descovy, all clinic visits and lab tests, NBC News reported. The guidance, issued … Read more